AAAAAA

   
Results: 1-14 |
Results: 14
A possible role for methotrexate in the treatment of childhood acute myeloid leukaemia, in particular for acute monocytic leukaemia
Authors: Rots, MG Pieters, R Jansen, G Kaspers, GJL Van Zantwijk, CH Noordhuis, P Voorn, DA Van Wering, ER Creutzig, U Veerman, AJP Peters, GJ
Citation: Mg. Rots et al., A possible role for methotrexate in the treatment of childhood acute myeloid leukaemia, in particular for acute monocytic leukaemia, EUR J CANC, 37(4), 2001, pp. 492-498
Post-induction residual leukemia in childhood acute lymphoblastic leukemiaquantified by PCR correlates with in vitro prednisolone resistance
Authors: Schmiegelow, K Nyvold, C Seyfarth, J Pieters, R Rottier, MMA Knabe, N Ryder, LP Madsen, HO Svejgaard, A Kaspers, GJL
Citation: K. Schmiegelow et al., Post-induction residual leukemia in childhood acute lymphoblastic leukemiaquantified by PCR correlates with in vitro prednisolone resistance, LEUKEMIA, 15(7), 2001, pp. 1066-1071
Modulation of glucocorticoid resistance in childhood acute lymphoblastic leukemia; Preliminary results
Authors: Haarman, EG Kaspers, GJL Pieters, R Rottier, MMA Veerman, AJP
Citation: Eg. Haarman et al., Modulation of glucocorticoid resistance in childhood acute lymphoblastic leukemia; Preliminary results, HEMAT BLOOD, 40, 2001, pp. 236-243
In-vitro cellular drug resistance in acute non-lymhoblastic leukemia: Comparisons between adults and children
Authors: de Haas, TGKJ Zwaan, CM Wondergem, MJ Pieters, R Kaspers, GJL Loonen, AH Rottier, MMA Wunsche, R Creutzig, U Bartl, S Hahlen, K Broxterman, HJ Ossenkoppele, GJ Veerman, AJP
Citation: Tgkj. De Haas et al., In-vitro cellular drug resistance in acute non-lymhoblastic leukemia: Comparisons between adults and children, HEMAT BLOOD, 40, 2001, pp. 244-250
Classification of ex vivo methotrexate resistance in acute lymphoblastic and myeloid leukaemia
Authors: Rots, MG Pieters, R Kaspers, GJL Veerman, AJP Peters, GJ Jansen, G
Citation: Mg. Rots et al., Classification of ex vivo methotrexate resistance in acute lymphoblastic and myeloid leukaemia, BR J HAEM, 110(4), 2000, pp. 791-800
Asparagine synthetase activity in paediatric acute leukaemias: AML-M5 subtype shows lowest activity
Authors: Dubbers, A Wurthwein, G Muller, HJ Schulze-Westhoff, P Winkelhorst, M Kurzknabe, E Lanvers, C Pieters, R Kaspers, GJL Creutzig, U Ritter, J Boos, J
Citation: A. Dubbers et al., Asparagine synthetase activity in paediatric acute leukaemias: AML-M5 subtype shows lowest activity, BR J HAEM, 109(2), 2000, pp. 427-429
Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia
Authors: Zwaan, CM Kaspers, GJL Pieters, R Ramakers-Van Woerden, NL den Boer, ML Wunsche, R Rottier, MMA Hahlen, K van Wering, ER Janka-Schaub, GE Creutzig, U Veerman, AJP
Citation: Cm. Zwaan et al., Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia, BLOOD, 96(8), 2000, pp. 2779-2786
Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia
Authors: Zwaan, CM Kaspers, GJL Pieters, R Woerden, NLR den Boer, ML Wunsche, R Rottier, MMA Hahlen, K van Wering, ER Janka-Schaub, GE Creutzig, U Veerman, AJP
Citation: Cm. Zwaan et al., Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia, BLOOD, 96(8), 2000, pp. 2879-2886
Effects of interleukin 3, interleukin 7, and B-cell growth factor on proliferation and drug resistance in vitro in childhood acute lymphoblastic leukemia
Authors: Duyn, AEJ Kaspers, GJL Pieters, R Van Zantwijk, CH Broekema, GJ Hahlen, K Veerman, AJP
Citation: Aej. Duyn et al., Effects of interleukin 3, interleukin 7, and B-cell growth factor on proliferation and drug resistance in vitro in childhood acute lymphoblastic leukemia, ANN HEMATOL, 78(4), 1999, pp. 163-171
Bcl-2 family members in childhood acute lymphoblastic leukemia: relationships with features at presentation, in vitro and in vivo drug response and long-term clinical outcome
Authors: Salomons, GS Smets, LA Verwijs-Janssen, M Hart, AAM Haarman, EG Kaspers, GJL Van Wering, ER Van Der Does-Van Den Berg, A Kamps, WA
Citation: Gs. Salomons et al., Bcl-2 family members in childhood acute lymphoblastic leukemia: relationships with features at presentation, in vitro and in vivo drug response and long-term clinical outcome, LEUKEMIA, 13(10), 1999, pp. 1574-1580
Different expression of glutathione S-transferase alpha, mu and pi in childhood acute lymphoblastic and myeloid leukaemia
Authors: Den Boer, ML Pieters, R Kazemier, KM Janka-Schaub, GE Henze, G Creutzig, U Kaspers, GJL Kearns, PR Hall, AG Pearson, ADJ Veerman, AJP
Citation: Ml. Den Boer et al., Different expression of glutathione S-transferase alpha, mu and pi in childhood acute lymphoblastic and myeloid leukaemia, BR J HAEM, 104(2), 1999, pp. 321-327
Circumvention of methotrexate resistance in childhood leukemia subtypes byrationally designed antifolates
Authors: Rots, MG Pieters, R Peters, GJ van Zantwijk, CH Mauritz, R Noordhuis, P Willey, JC Hahlen, K Creutzig, U Janka-Schaub, G Kaspers, GJL Veerman, AJP Jansen, G
Citation: Mg. Rots et al., Circumvention of methotrexate resistance in childhood leukemia subtypes byrationally designed antifolates, BLOOD, 94(9), 1999, pp. 3121-3128
Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia
Authors: Rots, MG Pieters, R Peters, GJ Noordhuis, P van Zantwijk, CH Kaspers, GJL Hahlen, K Creutzig, U Veerman, AJP Jansen, G
Citation: Mg. Rots et al., Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia, BLOOD, 93(5), 1999, pp. 1677-1683
Differential methotrexate resistance in childhood T- versus common/PreB-acute lymphoblastic leukemia can be measured by an in situ thymidylate synthase inhibition assay, but not by the MTT assay
Authors: Rots, MG Pieters, R Kaspers, GJL van Zantwijk, CH Noordhuis, P Mauritz, R Veerman, AJP Jansen, G Peters, GJ
Citation: Mg. Rots et al., Differential methotrexate resistance in childhood T- versus common/PreB-acute lymphoblastic leukemia can be measured by an in situ thymidylate synthase inhibition assay, but not by the MTT assay, BLOOD, 93(3), 1999, pp. 1067-1074
Risultati: 1-14 |